Immunology and Cell Biology

Papers
(The TQCC of Immunology and Cell Biology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Issue Information62
Highlight of 2023: Unconventional T cells: recent insights on development, trafficking and target cell recognition52
Issue Information40
A trial‐blazer in clinical research39
38
Small molecule. Big biology. Dual phosphatase inhibitor enters the immunotherapy fray35
Bridging science and accessibility: a tactile journey from gluten through to coeliac disease34
From science to sensory art: an inclusive pedagogical tool for the UK blind, low‐vision and diverse‐needs community to increase cervical cancer awareness27
MicroRNA‐mediated metabolic reprogramming of chimeric antigen receptor T cells19
What is Kindness in Science and why does it matter?19
Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegaloviru19
Dendritic cell–specific intercellular adhesion molecule‐3‐grabbing nonintegrin (DC‐SIGN) is a cellular receptor for delta inulin adjuvant17
Novel “Thetis” antigen‐presenting cells promote early life gut immune tolerance17
17
Microbe‐responsive human γδ T cells: the peculiar case of Staphylococcus aureus15
ADAM10 modulates the efficacy of T‐cell mediated therapy in solid tumors15
Identification of the immune repertoire of γδ T‐cell receptors in psoriasis14
14
Plasmodium falciparum and immune phagocytosis: characterization of the process13
A new way of identifying viral pathogens reactivating in cellular therapy products13
Nurturing a positive research culture within your organization13
Immunology in Montreal13
Need to know which MHCs protect against COVID? There's an App for that!12
Publication speed: a balancing act between author urgency and editorial process12
Mouse guanylate‐binding protein 1 does not mediate antiviral activity against influenza virus in vitro or in vivo12
ICB Special Feature: Highlights of 202412
T follicular helper cell responses to SARS‐CoV‐2 vaccination among healthy and immunocompromised adults11
CXCL11 expressing C57BL/6 mice have intact adaptive immune responses to viral infection11
Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft‐versus‐host disease development in humanized mice treated with post‐transplant cyclophosphamide11
Sex‐dimorphic gene regulation in murine macrophages across niches11
Highlight of 2023: Microglia biology10
Issue Information10
The future of scientific labs: how we are making our research more sustainable10
Age is just a number: long‐lasting T‐cell immunity can span several lifetimes10
Delta inulin alone or combined with CpG oligonucleotide enhances antibody‐dependent influenza vaccine protection in mice and nonhuman primate newborns10
Altered immunophenotypic expression in the peripheral bladder cancer immune landscape10
Targeting MAIT cells as a cellular adjuvant for humoral immunity: a new player in a very old game10
Indigenous student engagement in science: a case study addressing the lack of diversity and equity in biomedical science and pharmacy research for Aboriginal and Torres Strait islander people9
ZC3H12C expression in dendritic cells is necessary to prevent lymphadenopathy of skin‐draining lymph nodes9
Issue Information9
Unraveling the origins of pathogenic CXCL13+ helper T cells in systemic lupus erythematosus9
Single‐cell expression Quantitative Trait Loci: T‐cell immunology teams up with statistical genetics9
Improvement of human myeloid and natural killer cell development in humanized mice via hydrodynamic injection of transposon plasmids containing multiple human cytokine genes8
Type I interferon: it's all about intracellular TLR48
Chemical inhibition of DNA‐PKcs impairs the activation and cytotoxicity of CD4+ helper and CD8+ effector T cells8
The seductive allure of spatial biology: accelerating new discoveries in the life sciences8
Highlights of 2024: New insights into the molecular regulation of antibody‐secreting cells and their subsets8
Variations in the germinal center response revealed by genetically diverse mouse strains8
Immunology & Cell Biology Publication of the Year Awards 20237
Celebrating 100 years of Immunology & Cell Biology – a special focus on the field of tumor immunology in Australia7
CD137L and CD4 T cells limit BCL6‐expressing pre‐germinal center B cell expansion and BCL6‐driven B cell malignancy7
The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapy7
A tactile approach to introduce the skin autoimmune disease psoriasis to the general public and the vision‐impaired community7
The future of immunology: a Lofoten perspective7
Epigenomic variability is associated with age‐specific naïve CD4 T cell response to activation in infants and adolescents7
A long and winding road: the history of Immunology & Cell Biology from 1936 to 19876
CD4+ chimeric antigen receptor T cells in for the long journey6
Immunology in Practice: a modular framework to support Master of Science students conference attendance and engagement6
Failure to launch? Or a 30‐year career detour? A users’ manual for supporting second‐career scientists in your immunology lab6
RAGging on recombination signal sequence strength for diffusion‐mediated recombination6
6
A hybrid protein is a functional molecule to reduce the cytokine storm caused by excessively activated macrophages6
Help is on the way: critical roles of CD4+ T cells in infection and vaccination6
Survey of activation‐induced genome architecture reveals a novel enhancer of Myc6
Serological assays to measure dimeric IgA antibodies in SARS‐CoV‐2 infections6
Defining the proteomic landscape of cultured macrophages and their polarization continuum6
Choose your own T‐cell fate: creation of a narrative‐based, decision‐making activity to engage students in immunology6
6
Characterization of ex vivo expanded natural killer cells for cancer immunotherapy6
Self‐reactive B cells are increased in all major stages of peripheral development in Sjögren's disease6
For whom the B cells toll6
Circulating effector γδ T cell populations are associated with acute coronavirus disease 19 in unvaccinated individuals6
My winding career path6
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients6
In Semliki Forest virus encephalitis, suppressor of cytokine signaling 4 (SOCS4) is an essential modulator of immune responses that mediates the balance between immunopathology and virus clearance6
Issue Information6
The journey of young scientists in Brazil: challenges and perspectives6
Issue Information5
From chasing funding to a funding body5
The rising tide raises all ships5
Protein kinase D3 promotes neutrophil migration during viral infection5
Unleashing T cell responses to cancer through removal of intracellular checkpoints5
UNCovering new causes of monogenic systemic lupus erythematosus5
Art, science and inclusion: multisensory Sciart of immunology for blind, low‐vision and diverse‐needs audiences5
Therapy‐induced senescent cancer cells exhibit complement activation and increased complement regulatory protein expression5
The transcription factor SpiB regulates the fibroblastic reticular cell network and CD8+ T‐cell responses in lymph nodes5
Modeling the response to interleukin‐21 to inform natural killer cell immunotherapy5
Navigating the transition to Principal Investigator5
Anyone can cook, but only the fearless can be a great chef5
Interferon signaling in type‐2 dendritic cells supports TH2 and T follicular helper fates in response to allergens5
TLR9‐dependent dendritic cell maturation promotes IL‐6‐mediated upregulation of cathepsin X5
A new method to measure cell metabolism of rare cells in vivo reveals a high oxidative phosphorylation dependence of lung T cells5
Not an immune cell, but they may act like one—cells with immune properties outside the immune system5
A guide to relocating your laboratory5
Mucosal antibody responses following Vaxzevria vaccination5
Expanding strain coverage of a group A Streptococcus pilus–expressing Lactococcus lactis mucosal vaccine5
Phase 2 randomized controlled trial of seasonal influenza vaccine shows Advax® delta inulin adjuvant accelerates the humoral anti‐influenza response5
Immunologist Margaret Baird, a trailblazer in science and empowerment5
Touching the invisible: exploring intracellular host–pathogen interactions through multisensory art5
The evolving role of mast cells in wound healing: insights from recent research and diverse models5
Integrating functional metagenomics to decipher microbiome–immune interactions5
ADAM10 modulates the efficacy of T‐cell‐mediated therapy in solid tumors5
TGF‐β1 re‐programs TLR4 signaling in L. donovani infection: enhancement of SHP‐1 and ubiquitin‐editing enzyme A204
4
ICBSpecial Feature: Highlights of 20234
ChAdOx1 nCoV‐19 vaccination generates spike‐specific CD8+ T cells in aged mice4
New‐onset type 1 diabetes and severe acute respiratory syndrome coronavirus 2 infection4
Lymphopenia in sepsis—an acquired immunodeficiency?4
Sketching T cell atlases in the single‐cell era: challenges and recommendations4
Highlight of 2023: From fundamental studies to clinical trials, the importance of NK cells against cancer4
Downregulation of AT‐rich interaction domain 2 underlies natural killer cell dysfunction in oral squamous cell carcinoma4
Breaking down barriers with sensory science—improving accessibility to neuroimmunology for the blind and low‐vision communities4
Highlight of 2023: Thymic B cells—important players in the establishment of T‐cell tolerance4
METTL3 inhibition reduces N6‐methyladenosine levels and prevents allogeneic CD4+ T‐cell responses4
Th17 cells in cancer: plasticity‐driven immunopathology and therapeutic opportunity4
Nice and slow make the germinal centers go: measured and escalating antigen delivery enhance durability and quality of humoral immune responses against HIV‐14
Antigen presentation of post‐translationally modified peptides in major histocompatibility complexes4
Tyro3 deletion is protective in experimental autoimmune encephalomyelitis4
0.361328125